AbbVie Buy Hold or Sell Recommendation

ABBV -- USA Stock  

USD 68.00  0.54  0.79%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding AbbVie is 'Hold'. Macroaxis provides AbbVie buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. The advice algorithm takes into account all of AbbVie available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AbbVie buy-and-hold prospective. Check also AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell AbbVieBuy AbbVie


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon AbbVie has a risk adjusted performance of (0.07), jensen alpha of (0.39), total risk alpha of (0.89), sortino ratio of 0.0 and treynor ratio of (1.52)
Macroaxis provides unbiased buy, hold, or sell recommendation on AbbVie that should be used to complement current analysts and expert consensus on AbbVie. Our buy or sell advice engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure AbbVie is not overpriced, please confirm all AbbVie fundamentals including its Shares Outstanding, Net Income, Price to Earnings To Growth, as well as the relationship between Price to Book and Current Ratio . Given that AbbVie has Price to Earning of 19.46X, we suggest you validate AbbVie market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

AbbVie Trading Alerts and Improvement Suggestions

AbbVie generates negative expected return over the last 30 days
About 72.0% of the company shares are held by institutions such as insurance companies

AbbVie current analysts recommendations

Target Median Price84.50
Target Mean Price84.92
Recommendation Mean2.50
Target High Price115.00
Number Of Analyst Opinions12
Target Low Price73.00

AbbVie Returns Distribution Density

Mean Return0.35Value At Risk2.54
Potential Upside2.94Standard Deviation2.81
 Return Density 

AbbVie Greeks

Alpha over DOW
Beta against DOW=0.24
Overall volatility
Information ratio =0.17

AbbVie Volatility Alert

AbbVie exhibits very low volatility with skewness of -4.25 and kurtosis of 24.67. However, we advise investors to further study AbbVie technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare AbbVie to competition

AbbVie Fundamental Vs Peers

FundamentalsAbbViePeer Average
Return On Equity0.32% (0.31)%
Return On Asset12.02% (0.14)%
Profit Margin16.42% (1.27)%
Operating Margin42.72% (5.51)%
Current Valuation134.93B16.62B
Shares Outstanding1.48B571.82M
Shares Owned by Insiders0.09% 10.09%
Shares Owned by Institutions71.89% 39.21%
Number of Shares Shorted28.21M4.71M
Price to Earning19.46X28.72X
Price to Book43.51X9.51X
Price to Sales3.09X11.42X
Gross Profit25.04B27.38B
Net Income5.33B570.98M
Cash and Equivalents5.23B2.7B
Cash per Share3.54X5.01X
Total Debt37.92B5.32B
Debt to Equity9.53% 48.70%
Current Ratio1.04X2.16X
Book Value Per Share(5.29)X1.93K
Cash Flow from Operations11.14B971.22M
Short Ratio2.45X4.00X
Earnings Per Share3.51X3.12X
Price to Earnings To Growth1.49X4.89X
Number of Employees30K18.84K
Market Capitalization101B19.03B
Total Asset53.05B29.47B
Retained Earnings2.64B9.33B
Working Capital5.42B1.48B
Current Asset16.31B9.34B
   Exercise or conversion by Azita SalekiGerhardt of 2400 shares of AbbVie subject to Rule 16b-3 [view details]